Bacteriophages are the viruses with either DNA or RNA as the genetic material.
INTRODUCTION
Bacteriophages were discovered in 1951 by Towart. 3 He described degenerative changes present in staphylococcal colonies isolated from calf lymph, which could be transmitted serially by application of culture filtrates from the original growth. Bacteriophages are the viruses with either DNA or RNA as the genetic material and both singleand double-stranded forms of each are known. Phages have a developmental cycle within the host bacteria which can be lytic or lysogenic. The lytic cycle comprises a series of events that occur between attachment of phage particle to a bacterial cell and its subsequent release of daughter phage particles. Phage for a given bacterium can be isolated wherever that bacterium grows, such as in feces, sewage, soil, hot springs oceans. Water from the Ganges (India) has been found to be a rich source of vibrio phages. The problem is not isolating phage against particular bacteria but in selecting the ones most likely to be useful for clinical purposes. 4 
MORPHOLOGY
Certain bacteriophages that infect E. coli, called the T even phages (T2, T4, T6), have been studied in great detail and traditionally serve as the prototypes in describing the properties of bacteriophages.
T even phages have a complex and characteristic morphology (Fig. 1) . They are tadpole shaped, with a hexagonal head and a cylindrical tail. The head consists of a tightly packed core of nucleic acid (double-stranded DNA)
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surrounded by a protein coat or capsid. The size of the head varies in different phages from 28 to 100 nm. The tail is composed of a hollow core, and terminal base plate which has attached to it prongs, tail fibers or both.
Though most bacteriophages have the morphology and structure described above, phages have been identified that are spherical or filamentous and possess single stranded DNA or RNA.
LIFE CYCLE
Phages exhibit two different types of life cycle. In the virulent or lytic cycle, intracellular multiplication of the phage culminates in the lysis of the host bacterium and the release of progeny virus. In the temperate or lysogenic cycle the phage DNA becomes integrated with the bacterial genome, replicating synchronously with it, causing no harm to the host cell.
REVIEWS
Cislo et al studied the effect of concomitant topical and oral phage therapy on infected skin ulcers in 31 patients. There was marked improvement in 74.2% (23/31) patients which in seven patients the study could not be conducted due to side effects of phage therapy in the form of either eczema or pain or vomiting. 5 In 1974, studies were conducted in Tbilisi Georgia, by Sakandelidze et al who treated patients of antibiotic resistant osteomyelitis. Lung abscess, peritonitis and postsurgical wound infections with pyohage which is mixture of phage active against Staphylococcus, proteus and Streptococcus or diphage (Staphylococcus and proteus phages). Phage was applied subcutaneously or via the surgical drain daily for 5 to 10 days and improvement was seen in 92% of these cases. 
Bacteriophage as Antimicrobial Agents: A Milestone

JIAOMR
Weber et al in 1987 assessed the extent to which orally administered antistaphylococcal and antipseudomonal phage penetrated into the serum or urine of 56 patients with suppurative bacterial infection. By 10th day of therapy, it was found that 84% serum samples and 35% urine samples contained phage indicating a high bioavailablility. 6 In 1989 Kochetkova et al conducted a detailed and quantitative study in 131 cancer patients suffering postoperative would infections. Phages produced positive clinical results in 81.5% of patients. Phage therapy was found to be more effective for cutaneous would infections by local application than for pleural empyema, mediastinitis or osteomyelitis. Antipseudomonal phages were found to be most effective (86.7%) followed by staphylococcal (74.7%) phages. 6 
CLINICAL IMPLICATIONS
Phages have specific properties which give them advantages as therapeutic agents. They are self-replicating as well as self-limiting. They continue to multiply and penetrate deeper as long as local infection is present. This is sharp contrast to antibiotics which decrease in concentration below the site of infection. Phages are lytic against specific bacteria so they can be targeted more specifically than antibiotics which are active against a group of bacteria. Phages do not harm normal intestinal microflora. 7 Antibiotics have side effects which can be serious. But phages have been used in millions of patients without any reported side effects. Phages can be used prophylactically as well as in established infections. The self-perpetuating nature of phages in the presence of susceptible bacteria makes multiple administrations 8, 9 unnecessary. It also allows transfer of administered phages between animals in a farmyard.
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DISADVANTAGES
Problems faced in phages studies were poor understanding of heterogeneity and ecology of both the phages and the bacteria. Involved there was also difficulty in selecting appropriate mixture of phages of high virulence against the target bacteria. Failure to correctly and appropriately characterize the phage proportions was another reason for hampering the progress of these studies. Phages with high activity in vitro are more active in vivo. 9 Maintenance of phages by regular propagation needs expertise and an established setup.
CONCLUSION
Bacteriophages are bacterial vs that invade bacterial cells and are among the most abundant lining entities on earth playing important roles in maintaining the natural abundance and distribution of microorganisms. Phage therapy for eliminating multidrug resistant bacteria is gaining importance. There is need to carry out further studies on phages as therapeutic agents using specific phage stains against the corresponding bacterial hosts. Use of antibiotics along with phages has been tried with limited benefit because antibiotics are more likely to inhibit phage effectiveness than to enhance it and combination may result in problem/resistant genes. Hence, it is concluded that phage therapy alone is more effective.
